D-901-2013 Class III Terminated

Recalled by AbbVie Inc. — North Chicago, IL

FDA drug recall D-901-2013 was initiated by AbbVie Inc. on Aug 1, 2013 and is designated Class III. Reason for recall: Labeling: Incorrect Package Insert; product packaged with outdated version of the insert The recall status is terminated (terminated Nov 7, 2013). Affected quantity: 704 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 28, 2013
Initiation Date
Aug 1, 2013
Termination Date
Nov 7, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
704 bottles

Product description

Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA

Reason for recall

Labeling: Incorrect Package Insert; product packaged with outdated version of the insert

Distribution pattern

Nationwide

Code information

Lot 22033GY

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-901-2013
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for AbbVie Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-901-2013. Report a data issue: hello@regdatalab.com.